跳转至内容
Merck
所有图片(1)

Key Documents

EMU078421

Sigma-Aldrich

MISSION® esiRNA

targeting mouse Uba2

登录查看公司和协议定价
所有图片(1)

About This Item

分類程式碼代碼:
41105324
NACRES:
NA.51

描述

Powered by Eupheria Biotech

產品線

MISSION®

形狀

lyophilized powder

esiRNA cDNA 標靶序列

GCTCAGGTTGCCAAAGAAAGTGTGCTCCAGTTCCACCCCCAAGCCAACATTGAGGCTCACCATGACAGCATCATGAACCCAGACTATAATGTGGAGTTTTTTCGACAGTTTATATTGGTCATGAATGCATTAGATAACAGAGCTGCACGAAACCACGTGAATAGGATGTGTCTGGCCGCTGATGTGCCTCTCATTGAGAGCGGGACTGCTGGGTATCTCGGACAGGTGACCACTATCAAGAAGGGTGTGACTGAGTGTTACGAATGTCACCCTAAGCCTACCCAGAGGACGTTCCCTGGCTGTACGATTCGGAACACGCCTTCAGAACCTATCCATTGCATCGTATGGGCCAAGTATTTGTTCAACCAGCTGTTTGGAGAGGAAGATGCTGATCAAGAAGTGTCTCCTGACAGAGCTGACCCTGAGGCTGCTTGGGAACCAACAGAGGCTGAAGC

Ensembl | 小鼠類登錄號

ENSMUSG00000052997

NCBI登錄號

NM_016682

運輸包裝

ambient

儲存溫度

−20°C

基因資訊

mouse ... UBA2(50995) , Uba2(50995)

相关类别

一般說明

MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

法律資訊

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

儲存類別代碼

10 - Combustible liquids

閃點（°F）

Not applicable

閃點（°C）

Not applicable

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Xingyue He et al.
PloS one, 10(4), e0123882-e0123882 (2015-04-11)
SUMOylation is a post-translational ubiquitin-like protein modification pathway that regulates important cellular processes including chromosome structure, kinetochore function, chromosome segregation, nuclear and sub-nuclear organization, transcription and DNA damage repair. There is increasing evidence that the SUMO pathway is dysregulated in
Xiaoke Liu et al.
Journal of hematology & oncology, 8, 67-67 (2015-06-13)
SUMO-activating enzyme subunit 2 (SAE2) is the sole E1-activating enzyme required for numerous important protein SUMOylation, abnormal of which is associated with carcinogenesis. SAE2 inactivation was recently reported to be a therapeutic strategy in cancers with Myc overexpression. However, the

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门